Pathological role of HDAC8: cancer and beyond

JY Kim, H Cho, J Yoo, GW Kim, YH Jeon, SW Lee… - Cells, 2022 - mdpi.com
Histone deacetylase 8 (HDAC8) is a class I HDAC that catalyzes the deacetylation of histone
and non-histone proteins. As one of the best-characterized isoforms, numerous studies have …

Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy

M Zhou, M Yuan, M Zhang, C Lei, O Aras… - European journal of …, 2021 - Elsevier
Histone deacetylases (HDACs) play an important role in regulating the expression of genes
involved in tumorigenesis and tumor maintenance, and hence they have been considered …

Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension

P Chelladurai, C Kuenne, A Bourgeois… - Science Translational …, 2022 - science.org
Phenotypic alterations in resident vascular cells contribute to the vascular remodeling
process in diseases such as pulmonary (arterial) hypertension [P (A) H]. How the molecular …

Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside

F Sarno, G Benincasa, M List, AL Barabasi… - Clinical …, 2021 - Springer
Despite impressive efforts invested in epigenetic research in the last 50 years, clinical
applications are still lacking. Only a few university hospital centers currently use epigenetic …

Endothelial senescence: a new age in pulmonary hypertension

MK Culley, SY Chan - Circulation research, 2022 - Am Heart Assoc
Pulmonary hypertension is an enigmatic, deleterious disease driven by multiple
heterogeneous causes with a burgeoning proportion of older patients with complex, chronic …

Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

J Dave, V Jagana, R Janostiak, M Bisserier - Journal of Translational …, 2023 - Springer
Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the
remodeling of pulmonary blood vessels. If left unaddressed, PAH can lead to right heart …

Hdac8 inhibitor alleviates transverse aortic constriction‐induced heart failure in mice by downregulating Ace1

T Zhao, HJ Kee, SJ Kee… - Oxidative Medicine and …, 2022 - Wiley Online Library
Background. Heart failure is characterized by activation of the renin‐angiotensin‐
aldosterone system, which is involved in the regulation of cardiac hypertrophy and …

Switch-independent 3A: an epigenetic regulator in cancer with new implications for pulmonary arterial hypertension

K Jankowski, V Jagana, M Bisserier, L Hadri - Biomedicines, 2023 - mdpi.com
Epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding
RNA, play a crucial role in the regulation of gene expression and are pivotal in biological …

Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension

ADCU Ranasinghe, MA Schwarz - Biochemical Pharmacology, 2022 - Elsevier
Pulmonary arterial hypertension (PAH) is a devastating vascular disease with multiple
etiologies. Emerging evidence supports a fundamental role for epigenetic machinery and …

Mechanisms contributing to the dysregulation of miRNA-124 in pulmonary hypertension

H Zhang, A Laux, KR Stenmark, CJ Hu - International Journal of …, 2021 - mdpi.com
Chronic pulmonary hypertension (PH) is a fatal disease characterized by the persistent
activation of pulmonary vascular cells that exhibit aberrant expression of genes including …